Otsuka opts for majority JV as it links with Claris for IV products
This article was originally published in Scrip
Executive Summary
Following negotiations reported by Scrip earlier this week (scripintelligence.com, 4 December 2012), Otsuka Holdings has now announced a definitive agreement with India's Claris Lifesciences for a business tie-up in the area of intravenous solutions and clinical nutrition products.